U.S., Dec. 19 -- ClinicalTrials.gov registry received information related to the study (NCT07292714) titled 'A Study to Evaluate 9MW1911 in Patients With Chronic Obstructive Pulmonary Disease (COPD)' on Dec. 02.
Brief Summary: The study is a Phase II, multicenter, double-blind, randomized, parallel, placebo-controlled clinical trial designed to evaluate the efficacy, safety of 9MW1911 in patients with Chronic Obstructive Pulmonary Disease (COPD).
Study Start Date: July 15
Study Type: INTERVENTIONAL
Condition:
Chronic Obstructive Pulmonary Disease COPD
Intervention:
DRUG: 9MW1911
Participants will receive IV 9MW1911 in each dose every 28 days.
DRUG: Phase II placebo
Participants will receive IV placebo every 28 days.
Recruitment S...